Medicines That Reduce Stomach Acidity and Covid-19

The stomach is an important organ of the digestive system. In addition to digestion, it secretes various enzymes, hormones, and acid, which help kill / eliminate microorganisms entering the stomach. The stomach has an acidic pH level that it must maintain. The enzymes it secretes are very powerful and can damage its own tissue. The stomach therefore needs to protect itself from the acid and enzymes it secretes. It manages to do so through a special mucosal layer and its existing protective mechanisms. When these mechanisms are disrupted, the mucosal layer is damaged, or acid and enzyme secretion increases too much, our stomach is harmed. Diseases such as reflux and ulcers may develop as a result. (Source 1)
Because these diseases occur as a result of increased stomach acidity or impaired protection, treatment options that neutralize the stomach environment have begun to be used. PPI (Proton Pump Inhibitor) medicines reduce acid production in the cells lining the stomach and are among the most frequently prescribed medicines for people with stomach problems. Medicines in the PPI group include lansoprazol, pantoprazol, and esomeprazol. The World Health Organization (WHO) has also added PPIs to its list of essential medicines (4).
A Study Evaluating the Relationship Between PPI Use and Covid-19
In August 2020, the American Journal of Gastroenterology published a study on the effect of PPI use on Covid-19 risk, which was found to have increased. Researchers conducted an online survey of 53,130 patients between 3 May and 24 June 2020. The survey found that 3,386 people had tested positive for Covid-19. Taking into account the stomach acid-suppressing medicines these patients used, people taking PPIs were shown to have an increased risk of contracting Covid-19.
This risk was found to increase by an average of 2.2% in people taking a PPI 1 time a day and by 3.7% in those taking it 2 times a day.
No such effect was shown in people taking H2 receptor blockers (H2RB), another group of stomach acid-reducing medicines, for stomach complaints. This may be because PPIs suppress stomach acid more strongly. However, people taking low-dose PPIs were found to have fewer gastrointestinal manifestations of Covid-19, such as diarrhea and abdominal pain, than people who did not take them. (5)
Dr. Brennan M.R. Spiegel, one of the doctors who conducted the study, emphasizes when discussing it that PPI use should not be stopped because of this result. He stated that PPIs have benefits more important than their risks and that the dose-benefit relationship should be carefully assessed for patients before deciding about the medicine. He emphasized the importance of using the medicine at the lowest necessary dose and "when needed," as applies to every medicine. He noted that H2RB medicines could be used as an alternative treatment during this process.
It would be quite wrong to stop taking PPIs on our own out of concern about the study results discussed in this article. Remember that you take PPI medicines because you have a stomach problem. If you have concerns or questions about this topic, you can consult your physician for the most accurate information. To avoid contracting Covid-19, you should stay at home as much as possible; when you go out, wear your mask and follow distancing and hygiene rules.
RELATED TOPICS
- Covid-19: current worldwide and Türkiye statistics
- Latest News and Scientific Developments About Coronavirus
Sources
2. Definition and antagonism of histamine H 2 -receptors, Nature – April 1972
3. 25 Years of Proton Pump Inhibitors: A Comprehensive Review – January 2017
4. World Health Organization, Model List of Essential Medicines
5. Increased Risk of COVID-19 Among Users of Proton Pump Inhibitors, Journal of Gastroenterology – August 2020
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.